Former SAC portfolio manager Mathew Martoma was charged back in November 2012 in what is believed to be "the most lucrative" insider trading scheme ever. The complaints against him allege that the insider trading scheme involved information in pharmaceutical companies, Elan Corporation and Wyeth, between the summer 2006 and mid-July 2008.